These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 23086829)
21. Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice. Shin ED; Estall JL; Izzo A; Drucker DJ; Brubaker PL Gastroenterology; 2005 May; 128(5):1340-53. PubMed ID: 15887116 [TBL] [Abstract][Full Text] [Related]
22. Spilanthol, the Principal Alkylamide from Acmella oleracea, Attenuates 5-Fluorouracil-Induced Intestinal Mucositis in Mice. de Freitas-Blanco VS; Monteiro KM; de Oliveira PR; de Oliveira ECS; de Oliveira Braga LE; de Carvalho JE; Ferreira Rodrigues RA Planta Med; 2019 Feb; 85(3):203-209. PubMed ID: 30153691 [TBL] [Abstract][Full Text] [Related]
23. The protective effects of Aquilariae Lignum Resinatum extract on 5-Fuorouracil-induced intestinal mucositis in mice. Zheng H; Gao J; Man S; Zhang J; Jin Z; Gao W Phytomedicine; 2019 Feb; 54():308-317. PubMed ID: 30396718 [TBL] [Abstract][Full Text] [Related]
24. Regulatory role of Lactobacillus acidophilus on inflammation and gastric dysmotility in intestinal mucositis induced by 5-fluorouracil in mice. Justino PF; Melo LF; Nogueira AF; Morais CM; Mendes WO; Franco AX; Souza EP; Ribeiro RA; Souza MH; Soares PM Cancer Chemother Pharmacol; 2015 Mar; 75(3):559-67. PubMed ID: 25572363 [TBL] [Abstract][Full Text] [Related]
25. Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor. Boushey RP; Yusta B; Drucker DJ Cancer Res; 2001 Jan; 61(2):687-93. PubMed ID: 11212269 [TBL] [Abstract][Full Text] [Related]
26. Administration of probiotic mixture DM#1 ameliorated 5-fluorouracil-induced intestinal mucositis and dysbiosis in rats. Tang Y; Wu Y; Huang Z; Dong W; Deng Y; Wang F; Li M; Yuan J Nutrition; 2017 Jan; 33():96-104. PubMed ID: 27427511 [TBL] [Abstract][Full Text] [Related]
28. 5-HT₃ receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells. Yasuda M; Kato S; Yamanaka N; Iimori M; Matsumoto K; Utsumi D; Kitahara Y; Amagase K; Horie S; Takeuchi K Br J Pharmacol; 2013 Mar; 168(6):1388-400. PubMed ID: 23072534 [TBL] [Abstract][Full Text] [Related]
29. Potentiation of Glucagon-Like Peptide-2 Dynamics by Methotrexate Administration in Rat Small Intestine. Machida M; Shiga S; Machida T; Ohno M; Iizuka K; Hirafuji M Biol Pharm Bull; 2019; 42(10):1733-1740. PubMed ID: 31582661 [TBL] [Abstract][Full Text] [Related]
30. Emu Oil Combined with Lyprinol™ Reduces Small Intestinal Damage in a Rat Model of Chemotherapy-Induced Mucositis. Mashtoub S; Lampton LS; Eden GL; Cheah KY; Lymn KA; Bajic JE; Howarth GS Nutr Cancer; 2016 Oct; 68(7):1171-80. PubMed ID: 27618153 [TBL] [Abstract][Full Text] [Related]
31. Biological actions and therapeutic potential of the glucagon-like peptides. Drucker DJ Gastroenterology; 2002 Feb; 122(2):531-44. PubMed ID: 11832466 [TBL] [Abstract][Full Text] [Related]
32. 2'-Fucosyllactose Ameliorates Chemotherapy-Induced Intestinal Mucositis by Protecting Intestinal Epithelial Cells Against Apoptosis. Zhao G; Williams J; Washington MK; Yang Y; Long J; Townsend SD; Yan F Cell Mol Gastroenterol Hepatol; 2022; 13(2):441-457. PubMed ID: 34607083 [TBL] [Abstract][Full Text] [Related]
33. Glucagon-like peptide-2 improves both acute and late experimental radiation enteritis in the rat. Torres S; Thim L; Milliat F; Vozenin-Brotons MC; Olsen UB; Ahnfelt-Rønne I; Bourhis J; Benderitter M; François A Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1563-71. PubMed ID: 18035212 [TBL] [Abstract][Full Text] [Related]
34. Emu oil expedites small intestinal repair following 5-fluorouracil-induced mucositis in rats. Mashtoub S; Tran CD; Howarth GS Exp Biol Med (Maywood); 2013 Nov; 238(11):1305-17. PubMed ID: 24047797 [TBL] [Abstract][Full Text] [Related]
35. Losartan improves intestinal mucositis induced by 5-fluorouracil in mice. Oliveira MMB; de Araújo AA; Ribeiro SB; de Sales Mota PCM; Marques VB; da Silva Martins Rebouças C; Figueiredo JG; Barra PB; de Castro Brito GA; de Carvalho Leitão RF; Guerra GCB; de Medeiros CACX Sci Rep; 2021 Dec; 11(1):23241. PubMed ID: 34853351 [TBL] [Abstract][Full Text] [Related]
36. Non-invasive detection of a palifermin-mediated adaptive response following chemotherapy-induced damage to the distal small intestine of rats. Yazbeck R; Howarth GS; Borges L; Geier MS; Smith CL; Davidson GP; Butler RN Cancer Biol Ther; 2011 Sep; 12(5):399-406. PubMed ID: 21705855 [TBL] [Abstract][Full Text] [Related]
38. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives. Ribeiro RA; Wanderley CW; Wong DV; Mota JM; Leite CA; Souza MH; Cunha FQ; Lima-Júnior RC Cancer Chemother Pharmacol; 2016 Nov; 78(5):881-893. PubMed ID: 27590709 [TBL] [Abstract][Full Text] [Related]
39. The Protective Role of GMI, an Immunomodulatory Protein From Ganoderma microsporum, on 5-Fluorouracil-Induced Oral and Intestinal Mucositis. Li CH; Ko JL; Ou CC; Lin WL; Yen CC; Hsu CT; Hsiao YP Integr Cancer Ther; 2019; 18():1534735419833795. PubMed ID: 30879354 [TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor-alpha stimulates enterocyte proliferation and accelerates intestinal recovery following methotrexate-induced intestinal mucositis in a rat and a cell culture model. Sukhotnik I; Shteinberg D; Ben Lulu S; Bashenko Y; Mogilner JG; Ure BM; Shaoul R; Shamian B; Coran AG Pediatr Surg Int; 2008 Dec; 24(12):1303-11. PubMed ID: 18956197 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]